Novartis India

Sell

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE234A01025
NSEID: NOVARTIND
BSEID: 500672

INR

788.00

6.05 (0.77%)

BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 14.33 k

Click here to access the older version

Cash Flow

Novartis India Cash flow Statement

Figures in Rs cr

Standaloned Cash Flow Results

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Mar'19

Compare Cash Flow Results of Novartis India

Select Peers

Figures in Rs cr

standaloned Cash Flow Results

Change(INR)

Change(%)

Profit Before Tax

122.84

2259.57

-2,137.00

-94.56%

Adjustment

-56.75

161.91

-217.00

-135.05%

Changes In working Capital

9.04

-40.95

49.00

122.08%

Cash Flow after changes in Working Capital

75.13

2380.53

-2,305.00

-96.84%

Cash Flow from Operating Activities

113.4

1982.97

-1,869.00

-94.28%

Cash Flow from Investing Activities

33.13

-1919.22

1,952.00

101.73%

Cash Flow from Financing Activities

-120.99

-8.68

-112.00

-1293.89%

Net Cash Inflow / Outflow

25.54

55.07

-30.00

-53.62%

Opening Cash & Cash Equivalents

19.42

134.13

-115.00

-85.52%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

0.00

0.00%

Closing Cash & Cash Equivalent

44.96

189.2

-145.00

-76.24%

Cash Flow - Snapshot (Standalone) - Mar'24

YoY Growth in year ended Mar 2024 is 153.13% vs 15.85% in Mar 2023

Mar'24

Mar'23

Change(%)

Cash Flow from Operating Activities

113.40

44.80

153.13%